
Fluticasone furoate/vilanterol (Breo Ellipta/GlaxoSmithKline and Theravance Inc) approved for the once-daily treatment of asthma in patients aged 18 years and older.


Fluticasone furoate/vilanterol (Breo Ellipta/GlaxoSmithKline and Theravance Inc) approved for the once-daily treatment of asthma in patients aged 18 years and older.

For many years the dangers of opioid addiction have been well known. Taking the steps needed to reverse its impact has been slower in taking hold across the country.

The respiratory syncytial virus (RSV) may have finally met its match with a new approach to eradicating the harmful infection.

To prescribe or not to prescribe? – That is the question that practitioners face regarding antibiotics. While they can be extremely beneficial, the medication proved to be the deadly approach for one patient.

A study published in the Journal of Clinical Sleep Medicine found 44 percent of adults with sickle cell disease also experience sleeping difficulties.

A new antiviral combination is showing promise in treating patients with both chronic kidney disease and chronic hepatitis C, Texas researchers reported at the International Liver Congress in Vienna, Austria.

Canada- and Switzerland-based researchers discovered that a specific gene, that is typically associated with a rare disease, plays an important role in how pain is processed in the body.

Not only have researchers established a successful way to kill the potentially fatal Ebola virus, but the treatment can do so just days after infection.

A study of men with borderline testosterone levels found that half of them suffered either depressive symptoms or overt depression.

Many studies have looked at the link between vitamin D deficiency and liver disease. A Korean team recently examined whether vitamin D deficiency played a pivotal role in abnormal liver enzymes.

Huntington's Disease (HD) is an autosomal dominant progressive neurodegenerative disorder. In addition to the central nervous system disturbance the ailment causes, there is increasing evidence the genetic abnormality also affects peripheral organs and tissues.

New evidence has made it easier to differentiate between multiple sclerosis and vanishing white matter disease, conditions that can show considerable similarities.





Albumin -- the most abundant protein in the human body -- has many roles. It transports hormones, fatty acids, and other compounds. It buffers serum pH, and maintains osmotic pressure. Now, it appears that albumin may be a tool that could be used in diabetes management.

Analysis of a large patient cohort indicates that "isolated" events of atrial fibrillation precipitated by temporary secondary conditions tend to become chronic long-term cases of atrial fibrillation.

FDA approval of the left atrial appendage closure device after a long review process provides a potentially useful alternative to warfarin.

Japanese regulators recently approved the blockbuster hepatitis C drug Sovaldi as the first all-oral treatment regimen for genotype 2 patients in that country.

Lack of sleep and chronic kidney disease (CKD) independently lead to hypertension, diabetes mellitus, lower quality of life, and shorter life expectancy. Severity of CKD and sleep disturbances may also worsen diabetes and hypertension synergistically.

Commonly found in pain relievers, acetaminophen gets rid of more than just physical agony – it also diminishes emotions.

Study results show that incorrect use of inhalers and epinephrine autoinjectors is widespread among patients, which should prompt treating physicians to focus more on educating patients on proper use.

Lemtrada (alemtuzumab) injection is approved for the management of relapsing forms of multiple sclerosis (MS). In general, use of Lemtrada should be limited to patients with MS who have not had therapeutic success with 2 or more prior treatments.

How could an effective, inexpensive hepatitis C virus (HCV) drug have been available at local pharmacies without clinicians and patients knowing it? Researchers from the National Institutes of Health (NIH) have the answer.